← Browse by Condition
Medical Condition
relapsed
Total Trials
2
Recruiting Now
2
Trial Phases
EARLY_Phase 1
NCT02677064
Recruiting
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Enrollment
1,365 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT06732232 EARLY_Phase 1
Recruiting
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
Enrollment
12 pts
Location
China
Sponsor
Shanghai Cell Therapy Group Co...